Literature DB >> 494445

Renal elimination kinetics and plasma half-life of oxalate in man.

H Osswald, R Hautmann.   

Abstract

The renal handling of oxalate was studied by the injection of 14C-oxalate together with inulin as a glomerular marker into the renal artery in 6 patients. From the recovered amounts of the injected substances in the urine, time-concentration curves were constructed. Oxalate was excreted into urine 2.31 +/- 0.05 (SE) fold when compared to inulin. The maximal concentration of oxalate occurred at the same time as inulin, and there was no urinary precession of oxalate in comparison to inulin. From this part of the study we conclude that oxalate in addition to its filtered amount can probably enter the early part of nephron. In a second type of study, plasma levels of oxalate and inulin were observed over a period of 180 min, following intravenous injections in 7 volunteers. The decline of oxalate plasma concentrations followed first-order kinetics. Calculation of the rate constants of elimination assuming the 'one compartment open' model resulted in an oxalate to inulin ratio of 1.21 +/- 0.05. The oxalate half-life of elimination was 92 +/- 8 min, whereas that of inulin amounted to 112 +/- 9 min. The higher value of the calculated volume of distribution of oxalate compared to that of inulin indicates that oxalate enters a larger space than the extracellular fluid volume. The urinary recovery of intravenously injected oxalate was 97.2 +/- 1.4%, indicating that oxalate is excreted exclusively by the kidney. The observed differences of oxalate excretion, obtained with these two methods, could be attributed to the higher amount of ionized oxalate in the disequilibrium technique (rapid injections), entering the urine in a higher rate. Such a mechanism could explain the hyperoxaluria in calcium oxalate stone-forming patients.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 494445     DOI: 10.1159/000280294

Source DB:  PubMed          Journal:  Urol Int        ISSN: 0042-1138            Impact factor:   2.089


  13 in total

Review 1.  Oxalate transport and calcium oxalate renal stone disease.

Authors:  C F Verkoelen; J C Romijn
Journal:  Urol Res       Date:  1996

Review 2.  Primary and secondary hyperoxaluria: Understanding the enigma.

Authors:  Bhavna Bhasin; Hatice Melda Ürekli; Mohamed G Atta
Journal:  World J Nephrol       Date:  2015-05-06

Review 3.  The role of intestinal oxalate transport in hyperoxaluria and the formation of kidney stones in animals and man.

Authors:  Jonathan M Whittamore; Marguerite Hatch
Journal:  Urolithiasis       Date:  2016-12-02       Impact factor: 3.436

Review 4.  [Calcium oxalate stones and hyperoxaluria. What is certain? What is new?].

Authors:  M Straub; R E Hautmann; A Hesse; L Rinnab
Journal:  Urologe A       Date:  2005-11       Impact factor: 0.639

Review 5.  Lumasiran in the Management of Patients with Primary Hyperoxaluria Type 1: From Bench to Bedside.

Authors:  Viola D'Ambrosio; Pietro Manuel Ferraro
Journal:  Int J Nephrol Renovasc Dis       Date:  2022-06-17

6.  Correlation between the molecular effects of mutations at the dimer interface of alanine-glyoxylate aminotransferase leading to primary hyperoxaluria type I and the cellular response to vitamin B6.

Authors:  Mirco Dindo; Elisa Oppici; Daniele Dell'Orco; Rosa Montone; Barbara Cellini
Journal:  J Inherit Metab Dis       Date:  2017-11-06       Impact factor: 4.982

7.  Oxalate status in stone-formers. Two distinct hyperoxaluric entities.

Authors:  M Hatch
Journal:  Urol Res       Date:  1993-01

8.  Species differences in Cl- affinity and in electrogenicity of SLC26A6-mediated oxalate/Cl- exchange correlate with the distinct human and mouse susceptibilities to nephrolithiasis.

Authors:  Jeffrey S Clark; David H Vandorpe; Marina N Chernova; John F Heneghan; Andrew K Stewart; Seth L Alper
Journal:  J Physiol       Date:  2008-01-03       Impact factor: 5.182

9.  Partitioning of 14C-oxalate excretion in rats during a persistent oxalate challenge.

Authors:  Susan Ruth Marengo; Ailin Zhang; Edward J Traverso
Journal:  Urol Res       Date:  2008-10-16

10.  N-acetylcysteine protects against star fruit-induced acute kidney injury.

Authors:  Maria Heloisa Massola Shimizu; Pedro Henrique França Gois; Rildo Aparecido Volpini; Daniele Canale; Weverton Machado Luchi; Leila Froeder; Ita Pfeferman Heilberg; Antonio Carlos Seguro
Journal:  Ren Fail       Date:  2016-11-15       Impact factor: 2.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.